annual total liabilities:
$44.76B+$13.94B(+45.26%)Summary
- As of today (August 20, 2025), NVO annual total liabilities is $44.76 billion, with the most recent change of +$13.94 billion (+45.26%) on December 31, 2024.
- During the last 3 years, NVO annual total liabilities has risen by +$25.83 billion (+136.51%).
- NVO annual total liabilities is now at all-time high.
Performance
NVO Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$49.42B-$1.35B(-2.66%)Summary
- As of today (August 20, 2025), NVO quarterly total liabilities is $49.42 billion, with the most recent change of -$1.35 billion (-2.66%) on June 1, 2025.
- Over the past year, NVO quarterly total liabilities has increased by +$12.50 billion (+33.87%).
- NVO quarterly total liabilities is now -2.66% below its all-time high of $50.77 billion, reached on March 31, 2025.
Performance
NVO quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NVO Total liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +45.3% | +33.9% |
3 y3 years | +136.5% | +143.3% |
5 y5 years | +338.0% | +331.1% |
NVO Total liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +136.5% | -2.7% | +143.3% |
5 y | 5-year | at high | +338.0% | -2.7% | +331.1% |
alltime | all time | at high | >+9999.0% | -2.7% | >+9999.0% |
NVO Total liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $49.42B(-2.7%) |
Mar 2025 | - | $50.77B(+13.4%) |
Dec 2024 | $44.76B(+45.3%) | $44.76B(+8.0%) |
Sep 2024 | - | $41.46B(+12.3%) |
Jun 2024 | - | $36.91B(+27.5%) |
Mar 2024 | - | $28.96B(-6.0%) |
Dec 2023 | $30.81B(+36.1%) | $30.81B(+4.8%) |
Sep 2023 | - | $29.41B(+5.5%) |
Jun 2023 | - | $27.88B(+12.3%) |
Mar 2023 | - | $24.82B(+9.6%) |
Dec 2022 | $22.64B(+19.7%) | $22.64B(+3.4%) |
Sep 2022 | - | $21.89B(+7.8%) |
Jun 2022 | - | $20.31B(+4.0%) |
Mar 2022 | - | $19.53B(+3.2%) |
Dec 2021 | $18.92B(+41.1%) | $18.92B(+12.4%) |
Sep 2021 | - | $16.83B(+14.0%) |
Jun 2021 | - | $14.76B(+12.7%) |
Mar 2021 | - | $13.10B(-2.3%) |
Dec 2020 | $13.41B(+31.3%) | $13.41B(+5.9%) |
Sep 2020 | - | $12.66B(+10.5%) |
Jun 2020 | - | $11.46B(+8.5%) |
Mar 2020 | - | $10.57B(+3.4%) |
Dec 2019 | $10.22B(+13.2%) | $10.22B(-2.8%) |
Sep 2019 | - | $10.51B(+6.2%) |
Jun 2019 | - | $9.89B(+4.7%) |
Mar 2019 | - | $9.45B(+4.7%) |
Dec 2018 | $9.03B(+6.5%) | $9.03B(+6.6%) |
Sep 2018 | - | $8.47B(-0.2%) |
Jun 2018 | - | $8.49B(+4.3%) |
Mar 2018 | - | $8.14B(-4.0%) |
Dec 2017 | $8.47B(+14.3%) | $8.47B(+4.7%) |
Sep 2017 | - | $8.09B(+6.8%) |
Jun 2017 | - | $7.58B(-2.3%) |
Mar 2017 | - | $7.75B(+4.6%) |
Dec 2016 | $7.41B(+13.6%) | $7.41B(+6.8%) |
Sep 2016 | - | $6.94B(+1.8%) |
Jun 2016 | - | $6.82B(-1.1%) |
Mar 2016 | - | $6.90B(+5.7%) |
Dec 2015 | $6.53B(+9.2%) | $6.53B(+3.6%) |
Sep 2015 | - | $6.30B(-0.1%) |
Jun 2015 | - | $6.30B(-3.3%) |
Mar 2015 | - | $6.52B(+9.1%) |
Dec 2014 | $5.97B(+16.5%) | $5.97B(+5.7%) |
Sep 2014 | - | $5.65B(+13.9%) |
Jun 2014 | - | $4.96B(-9.4%) |
Mar 2014 | - | $5.47B(+6.7%) |
Dec 2013 | $5.13B(+15.9%) | $5.13B(-2.6%) |
Sep 2013 | - | $5.27B(+4.4%) |
Jun 2013 | - | $5.04B(+2.2%) |
Mar 2013 | - | $4.93B(+11.5%) |
Dec 2012 | $4.42B(-7.0%) | $4.42B(-17.2%) |
Sep 2012 | - | $5.34B(+5.6%) |
Jun 2012 | - | $5.06B(-2.0%) |
Mar 2012 | - | $5.16B(+8.5%) |
Dec 2011 | $4.76B | $4.76B(-0.7%) |
Sep 2011 | - | $4.79B(+0.4%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2011 | - | $4.77B(+3.5%) |
Mar 2011 | - | $4.61B(+4.8%) |
Dec 2010 | $4.40B(+30.0%) | $4.40B(+4.9%) |
Sep 2010 | - | $4.19B(+9.0%) |
Jun 2010 | - | $3.85B(-0.3%) |
Mar 2010 | - | $3.86B(+14.1%) |
Dec 2009 | $3.38B(+13.8%) | $3.38B(+5.6%) |
Sep 2009 | - | $3.21B(+8.6%) |
Jun 2009 | - | $2.95B(-4.2%) |
Mar 2009 | - | $3.08B(+3.6%) |
Dec 2008 | $2.97B(+16.5%) | $2.97B(+5.0%) |
Sep 2008 | - | $2.83B(-0.1%) |
Jun 2008 | - | $2.84B(-3.3%) |
Mar 2008 | - | $2.93B(+14.9%) |
Dec 2007 | $2.55B(+14.1%) | $2.55B(-0.2%) |
Sep 2007 | - | $2.56B(+10.1%) |
Jun 2007 | - | $2.32B(-0.7%) |
Mar 2007 | - | $2.34B(+4.6%) |
Dec 2006 | $2.24B(+5.3%) | $2.24B(-7.0%) |
Sep 2006 | - | $2.41B(+8.3%) |
Jun 2006 | - | $2.22B(+2.3%) |
Mar 2006 | - | $2.17B(+2.2%) |
Dec 2005 | $2.13B(+14.5%) | $2.13B(+4.1%) |
Sep 2005 | - | $2.04B(+11.3%) |
Jun 2005 | - | $1.84B(+3.3%) |
Mar 2005 | - | $1.78B(-4.3%) |
Dec 2004 | $1.86B(+19.5%) | $1.86B(+18.7%) |
Sep 2004 | - | $1.56B(+8.7%) |
Jun 2004 | - | $1.44B(-4.1%) |
Mar 2004 | - | $1.50B(-3.4%) |
Dec 2003 | $1.55B(+28.3%) | $1.55B(+1.8%) |
Jun 2003 | - | $1.53B(+13.9%) |
Mar 2003 | - | $1.34B(+10.6%) |
Dec 2002 | $1.21B(+15.3%) | $1.21B(+15.3%) |
Dec 2001 | $1.05B(-5.7%) | $1.05B(-4.5%) |
Mar 2001 | - | $1.10B(-1.3%) |
Dec 2000 | $1.11B(-33.3%) | $1.11B(+4.4%) |
Dec 1999 | $1.67B(+14.3%) | $1.07B(-26.8%) |
Dec 1998 | $1.46B(+33.7%) | $1.46B(+32.3%) |
Dec 1997 | $1.09B(+3.3%) | $1.10B(+4.6%) |
Dec 1996 | $1.06B(-9.1%) | $1.05B(+2.1%) |
Dec 1995 | $1.16B(-11.4%) | $1.03B(-21.5%) |
Dec 1994 | $1.31B(+22.8%) | $1.31B(+22.2%) |
Dec 1993 | $1.07B(+7.7%) | $1.08B(+8.2%) |
Dec 1992 | $994.16M(+1.9%) | $994.29M(+1.9%) |
Dec 1991 | $975.76M(+3.1%) | $975.82M(+3.1%) |
Dec 1990 | $946.71M(+15.7%) | $946.22M(+15.9%) |
Dec 1989 | $818.15M(+55.3%) | $816.44M(+51.8%) |
Dec 1988 | $526.67M(+5.0%) | $537.70M(+5.8%) |
Dec 1987 | $501.42M(+15.3%) | $508.19M(-8.4%) |
Dec 1986 | $434.77M(+59.9%) | $554.52M(+103.3%) |
Dec 1985 | $271.89M(+21.2%) | $272.73M(+21.2%) |
Dec 1984 | $224.37M(+16.0%) | $225.10M |
Dec 1983 | $193.39M(+5.9%) | - |
Dec 1982 | $182.70M(+2.7%) | - |
Dec 1981 | $177.84M(+3.8%) | - |
Dec 1980 | $171.27M | - |
FAQ
- What is Novo Nordisk A/S annual total liabilities?
- What is the all time high annual total liabilities for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual total liabilities year-on-year change?
- What is Novo Nordisk A/S quarterly total liabilities?
- What is the all time high quarterly total liabilities for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly total liabilities year-on-year change?
What is Novo Nordisk A/S annual total liabilities?
The current annual total liabilities of NVO is $44.76B
What is the all time high annual total liabilities for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual total liabilities is $44.76B
What is Novo Nordisk A/S annual total liabilities year-on-year change?
Over the past year, NVO annual total liabilities has changed by +$13.94B (+45.26%)
What is Novo Nordisk A/S quarterly total liabilities?
The current quarterly total liabilities of NVO is $49.42B
What is the all time high quarterly total liabilities for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly total liabilities is $50.77B
What is Novo Nordisk A/S quarterly total liabilities year-on-year change?
Over the past year, NVO quarterly total liabilities has changed by +$12.50B (+33.87%)